Thomas R Ulich - Net Worth and Insider Trading

Thomas R Ulich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas R Ulich owns 2 companies in total, including InVivo Therapeutics Holdings Corp (NVIVQ) , and Alnylam Pharmaceuticals Inc (ALNY) .

Click here to see the complete history of Thomas R Ulich’s form 4 insider trades.

Insider Ownership Summary of Thomas R Ulich

Ticker	Comapny	Transaction Date	Type of Owner
NVIVQ	InVivo Therapeutics Holdings Corp	2014-02-24	Chief Scientific Officer
ALNY	Alnylam Pharmaceuticals Inc	2004-05-27	Sr VP Research and Development

Thomas R Ulich Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas R Ulich Ownership Network

Ownership Network List of Thomas R Ulich

No Data

Ownership Network Relation of Thomas R Ulich

Thomas R Ulich Owned Company Details

What does InVivo Therapeutics Holdings Corp do?

Who are the key executives at InVivo Therapeutics Holdings Corp?

Thomas R Ulich is the Chief Scientific Officer of InVivo Therapeutics Holdings Corp. Other key executives at InVivo Therapeutics Holdings Corp include 10 percent owner Brice Foose , Chief Financial Officer Richard Christopher , and director & CEO and CMO Richard M. Toselli .

InVivo Therapeutics Holdings Corp (NVIVQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InVivo Therapeutics Holdings Corp (NVIVQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

InVivo Therapeutics Holdings Corp Insider Transactions

No Available Data

Thomas R Ulich Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas R Ulich. You might contact Thomas R Ulich via mailing address: C/o Invivo Therapeutics Holdings Corp., One Kendall Square, Suite B14402, Cambridge Ma 02139.

Discussions on Thomas R Ulich

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.